{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:51Z","timestamp":1793726511929,"version":"4.6.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1080\/14734220601142878","type":"journal-article","created":{"date-parts":[[2007,11,28]],"date-time":"2007-11-28T03:06:11Z","timestamp":1196219171000},"page":"308-314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":161,"title":["N-acetylcysteine and neurodegenerative diseases: Basic and clinical pharmacology"],"prefix":"10.1007","volume":"6","author":[{"given":"Motoki","family":"Arakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,1]]},"reference":[{"key":"64308_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1378\/chest.105.3.806","volume":"105","author":"A Vecchiarelli","year":"1994","unstructured":"Vecchiarelli A, Dottorini M, Pietrella D, Cociani C, Eslami A, Todisco T, Bistoni F. Macrophage activation by N-acetylcysteine in COPD patients. Chest. 1994;105:806\u201311.","journal-title":"Chest."},{"key":"64308_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1749-6632.1963.tb16647.x","volume":"106","author":"AL Sheffner","year":"1963","unstructured":"Sheffner AL. The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine. Ann N Y Acad Sci. 1963;106:298\u2013310.","journal-title":"Ann N Y Acad Sci."},{"key":"64308_CR3","first-page":"405","volume":"64","author":"G Boman","year":"1983","unstructured":"Boman G, B\u00e4cker U, Larsson S, Melander B, W\u00e5hlander L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: Report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis. 1983;64:405\u201315.","journal-title":"Eur J Respir Dis."},{"key":"64308_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2165\/00003495-198325030-00002","volume":"25","author":"LF Prescott","year":"1983","unstructured":"Prescott LF. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs. 1983;25:290\u2013314.","journal-title":"Drugs."},{"key":"64308_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1378\/chest.105.1.190","volume":"105","author":"PM Suter","year":"1994","unstructured":"Suter PM, Domenighetti G, Schaller MD, Laverri\u00e9re MC, Ritz R, Perret C. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest. 1994;105:190\u20134.","journal-title":"Chest."},{"key":"64308_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0009-2797(94)03332-3","volume":"94","author":"B S\u00e4rnstrand","year":"1995","unstructured":"S\u00e4rnstrand B, Tunek A, Sj\u00f6din K, Hallberg A. Effects of N-acetylcysteine stereoisomers on oxygen-induced lung injury in rats. Chem Biol Interact. 1995;94:157\u201364.","journal-title":"Chem Biol Interact."},{"key":"64308_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/01.STR.26.2.305","volume":"26","author":"NW Knuckey","year":"1995","unstructured":"Knuckey NW, Palm D, Primiano M, Epstein MH, Johanson CE. N-acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke. 1995;26:305\u201311.","journal-title":"Stroke."},{"key":"64308_CR8","first-page":"333","volume":"292","author":"J Miquel","year":"1995","unstructured":"Miquel J, Ferr\u00e1ndiz ML, De Juan E, Sevila, I, Mart\u00ednez M. N-acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria. Eur J Pharmacol. 1995;292:333\u20135.","journal-title":"Eur J Pharmacol."},{"key":"64308_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/aid.1995.11.141","volume":"11","author":"A Witschi","year":"1995","unstructured":"Witschi A, Junker E, Schranz C, Speck RF, Lauterburg BH. Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS. AIDS Res Hum Retroviruses. 1995;11:141\u20133.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"64308_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.pa.36.040196.000503","volume":"36","author":"NA Simonian","year":"1996","unstructured":"Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Ann Rev Pharmacol Toxicol. 1996;36:83\u2013106.","journal-title":"Ann Rev Pharmacol Toxicol."},{"key":"64308_CR11","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/0006-2952(87)90200-0","volume":"36","author":"IA Cotgreave","year":"1987","unstructured":"Cotgreave IA, Sandy MS, Berggren M, Mold\u00e9us PW, Smith MT. N-acetylcysteine and glutathione-dependent protective effect of PZ51 (Ebselen) against diquat-induced cytotoxicity in isolated hepatocytes. Biochem Pharmacol. 1987;36:2899\u2013904.","journal-title":"Biochem Pharmacol."},{"key":"64308_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neures.2006.03.008","volume":"55","author":"M Arakawa","year":"2006","unstructured":"Arakawa M, Ushimaru N, Osada N, Oda T, Ishige K, Ito Y. N-acetylcysteine selectively protects cerebellar granule cells from 4-hydroxynonenal-induced cell death. Neurosci Res. 2006;55:255\u201363.","journal-title":"Neurosci Res."},{"key":"64308_CR13","doi-asserted-by":"publisher","first-page":"7496","DOI":"10.1073\/pnas.91.16.7496","volume":"91","author":"M Mayer","year":"1994","unstructured":"Mayer M, Noble M. N-acetyl-l-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA. 1994;91:7496\u2013500.","journal-title":"Proc Natl Acad Sci USA."},{"key":"64308_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01870891","volume":"89","author":"S Bannai","year":"1986","unstructured":"Bannai S, Tateishi N. Role of membrane transport in metabolism and function of glutathione in mammals. J Membr Biol. 1986;89:1\u20138.","journal-title":"J Membr Biol."},{"key":"64308_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.neuint.2005.07.010","volume":"47","author":"K Ishige","year":"2005","unstructured":"Ishige K, Tanaka M, Arakawa M, Saito H, Ito Y. Distinct nuclear factor-\u03baB\/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells. Neurochem Int. 2005;47:545\u201355.","journal-title":"Neurochem Int."},{"key":"64308_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0955-2863(97)00113-7","volume":"8","author":"CK Sen","year":"1997","unstructured":"Sen CK. Nutritional biochemistry of cellular glutathione. J Nutr Biochem. 1997;8:660\u201372.","journal-title":"J Nutr Biochem."},{"key":"64308_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0076-6879(95)51106-7","volume":"251","author":"A Meister","year":"1995","unstructured":"Meister A. Glutathione metabolism. Meth Enzymol. 1995;251:3\u20137.","journal-title":"Meth Enzymol."},{"key":"64308_CR18","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0021-9258(19)41830-9","volume":"250","author":"PG Richman","year":"1975","unstructured":"Richman PG, Meister A. Regulation of \u03b3-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione. J Biol Chem 1975;250:1422\u20136.","journal-title":"J Biol Chem"},{"key":"64308_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","volume":"57","author":"DM Townsend","year":"2003","unstructured":"Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother. 2003;57:145\u201355.","journal-title":"Biomed Pharmacother."},{"key":"64308_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0163-7258(90)90048-7","volume":"47","author":"EA Bump","year":"1990","unstructured":"Bump EA, Brown JM. Role of glutathione in the radiation response of mammalian cells in vitro and in vivo Pharmacol Ther. 1990;47:117\u201336.","journal-title":"Pharmacol Ther."},{"key":"64308_CR21","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1523\/JNEUROSCI.15-04-02857.1995","volume":"15","author":"G Ferrari","year":"1995","unstructured":"Ferrari G, Yan CY, Greene LA. N-acetylcysteine (d- and l-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci. 1995;15:2857\u201366.","journal-title":"J Neurosci."},{"key":"64308_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","volume":"6","author":"OI Aruoma","year":"1989","unstructured":"Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593\u20137.","journal-title":"Free Radic Biol Med."},{"key":"64308_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/0076-6879(94)34119-2","volume":"234","author":"P Mold\u00e9us","year":"1994","unstructured":"Mold\u00e9us P, Cotgreave IA. N-acetylcysteine. Methods Enzymol. 1994;234:482\u201392.","journal-title":"Methods Enzymol."},{"key":"64308_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0076-6879(95)51133-4","volume":"251","author":"GP Biewenga","year":"1995","unstructured":"Biewenga GP, Bast A. Reaction of lipoic acid with ebselen and hypochlorous acid. Meth Enzymol. 1995;251:303\u201314.","journal-title":"Meth Enzymol."},{"key":"64308_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/0076-6879(94)34118-4","volume":"234","author":"H Sies","year":"1994","unstructured":"Sies H. Ebselen: A glutathione peroxidase mimic. Methods Enzymol. 1994;234:476\u201382.","journal-title":"Methods Enzymol."},{"key":"64308_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1021\/tx950115u","volume":"9","author":"H Masumoto","year":"1996","unstructured":"Masumoto H, Sies H. The reaction of ebselen with peroxynitrite. Chem Res Toxicol. 1996;9:262\u20137.","journal-title":"Chem Res Toxicol."},{"key":"64308_CR27","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1021\/jo00266a018","volume":"54","author":"RS Glass","year":"1989","unstructured":"Glass RS, Farooqui R, Sabahi M, Ehler KW. Formation of thiocarbonyl compounds in the reaction of ebselen oxide with thiols. J Org Chem. 1989;54:1092\u20137.","journal-title":"J Org Chem."},{"key":"64308_CR28","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1523\/JNEUROSCI.17-13-05089.1997","volume":"17","author":"I Kruman","year":"1997","unstructured":"Kruman I, Bruce-Keller AJ, Bredesen D Waeg G, Mattson MI. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci. 1997;17:5089\u2013100.","journal-title":"J Neurosci."},{"key":"64308_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0098-2997(03)00017-7","volume":"24","author":"YC Awasthi","year":"2003","unstructured":"Awasthi YC, Sharma R, Cheng JZ, Yang Y, Sharma A, Singhal SS, Awasthi S. Role of 4-hydroxynonenal in stressmediated mediated apoptosis signaling. Mol Aspects Med. 2003;24:219\u201330.","journal-title":"Mol Aspects Med"},{"key":"64308_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1046\/j.1471-4159.1997.69020570.x","volume":"69","author":"EM Blanc","year":"1997","unstructured":"Blanc EM, Kelly JF, Mark RJ, Waeg G, Mattson MP. 4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action on G\u03b1q\/11. J Neurochem. 1997;69:570\u201380.","journal-title":"J Neurochem."},{"key":"64308_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1515\/REVNEURO.1998.9.2.105","volume":"9","author":"JN Keller","year":"1998","unstructured":"Keller JN, Mattson MP. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci. 1998;9:105\u201316.","journal-title":"Rev Neurosci."},{"key":"64308_CR32","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/S0891-5849(00)00411-1","volume":"29","author":"MD Neely","year":"2000","unstructured":"Neely MD, Zimmerman L, Picklo MJ, Ou JJ, Morales CR, Montine KS, Amaranth V Montine TJ. Congeners of N\u03b1-acetyl-l-cysteine but not aminoguanidine act as neuro-protectants from the lipid peroxidation product 4-hydroxy-2-nonenal. Free Radic Biol Med. 2000;29:1028\u201336.","journal-title":"Free Radic Biol Med."},{"key":"64308_CR33","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1046\/j.1471-4159.1999.721617.x","volume":"72","author":"MJ Picklo","year":"1999","unstructured":"Picklo MJ, Amarnath V, McIntyre JO, Graham DG, Montine TJ. 4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites. J Neurochem. 1999;72:1617\u201324.","journal-title":"J Neurochem."},{"key":"64308_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neulet.2004.08.015","volume":"370","author":"T Akaishi","year":"2004","unstructured":"Akaishi T, Nakazawa K, Sato K, Ohno Y, Ito, Y. 4-Hydroxynonenal modulates the long-term potentiation induced by L-type Ca2+ channel activation in the rat dentate gyrus in vitro Neurosci Lett. 2004;370:155\u20139.","journal-title":"Neurosci Lett."},{"key":"64308_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1248\/bpb.27.174","volume":"27","author":"T Akaishi","year":"2004","unstructured":"Akaishi T, Nakazawa K, Sato K, Saito H, Ohno Y, Ito Y. Modulation of voltage-gated Ca2+ current by 4-hydroxynonenal in dentate granule cells. Biol Pharm Bull. 2004;27:174\u20139.","journal-title":"Biol Pharm Bull."},{"key":"64308_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0197-4580(98)00009-8","volume":"19","author":"WR Markesbery","year":"1998","unstructured":"Markesbery WR Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer\u2019s disease. Neurobiol Aging. 1998;19:33\u20136.","journal-title":"Neurobiol Aging."},{"key":"64308_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/qjmed\/94.9.485","volume":"94","author":"LT McGrath","year":"2001","unstructured":"McGrath LT, McGleenon BM, Brennan S, McColl D, McILroy S Passmore AP. Increased oxidative stress in Alzheimer\u2019s disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM. 2001;94:485\u201390.","journal-title":"QJM."},{"key":"64308_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0022-510X(00)00296-3","volume":"175","author":"T Yamashita","year":"2000","unstructured":"Yamashita T, Ando Y, Obayashi K, Terazaki H, Sakashita N, Uchida K, Ohama E, Ando M, Uchino M. Oxidative injury is present in Purkinje cells in patients with olivopontocerebellar atrophy. J Neurol Sci. 2000;175:107\u201310.","journal-title":"J Neurol Sci."},{"key":"64308_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0168-0102(99)00097-8","volume":"35","author":"Y Ito","year":"1999","unstructured":"Ito Y, Arakawa M, Ishige K, Fukuda H. Comparative study of survival signal withdrawal- and 4-hydroxynonenal-induced cell death in cerebellar granule cells. Neurosci Res. 1999;35:321\u20137.","journal-title":"Neurosci Res."},{"key":"64308_CR40","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.neuroscience.2003.08.026","volume":"122","author":"Y Kosuge","year":"2003","unstructured":"Kosuge Y, Koen Y, Ishige K, Minami K, Urasawa H, Saito H, Ito Y. S-allyl-L-cysteine selectively protects cultured rat hippocampal neurons from amyloid \u03b2-protein-and tunica-mycin-induced neuronal death. Neuroscience. 2003;122: 885\u201395.","journal-title":"Neuroscience."},{"key":"64308_CR41","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1021\/tx049843k","volume":"17","author":"MJ Meyer","year":"2004","unstructured":"Meyer MJ, Mosely DE, Amarnath V, Picklo MJ. Metabolism of 4-hydroxy-trans-2-nonenal by central nervous system mitochondria is dependent on age and NAD+ availability. Chem Res Toxicol. 2004;17:1272\u20139.","journal-title":"Chem Res Toxicol."},{"key":"64308_CR42","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1046\/j.1471-4159.2003.01628.x","volume":"84","author":"TC Murphy","year":"2003","unstructured":"Murphy TC, Amarnath V, Picklo MJ. Mitochondrial oxidation of 4-hydroxy-2-nonenal in rat cerebral cortex. J Neurochem. 2003;84:1313\u201321.","journal-title":"J Neurochem."},{"key":"64308_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0378-4274(99)00301-X","volume":"114","author":"A Laurent","year":"2000","unstructured":"Laurent A, Perdu-Durand E, Alary J, Debrauwer L, Cravedi JP. Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices. Toxicol Lett. 2000;114:203\u201314.","journal-title":"Toxicol Lett."},{"key":"64308_CR44","doi-asserted-by":"publisher","first-page":"10893","DOI":"10.1074\/jbc.273.18.10893","volume":"273","author":"S Srivastava","year":"1998","unstructured":"Srivastava S, Chandra A, Wang LF, Seifert WE, DaGue BB, Ansari NH, Srivastava SK, Bhatnagar A. Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J Biol Chem. 1998;273: 10893\u2013900.","journal-title":"J Biol Chem."},{"key":"64308_CR45","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0968-0004(00)01674-1","volume":"25","author":"S Raha","year":"2000","unstructured":"Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci. 2000;25:502\u20138.","journal-title":"Trends Biochem Sci."},{"key":"64308_CR46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0891-5849(98)00186-5","volume":"25","author":"C Xie","year":"1998","unstructured":"Xie C, Lovell MA, Markesbery WR. Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. Free Radic Biol Med. 1998;25:979\u201388.","journal-title":"Free Radic Biol Med."},{"key":"64308_CR47","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0006-2952(98)00228-7","volume":"56","author":"SV Bhagwat","year":"1998","unstructured":"Bhagwat SV, Vijayasarathy C, Raza H, Mullick J, Avadhani NG. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochem Pharmacol. 1998;56:831\u20139.","journal-title":"Biochem Pharmacol."},{"key":"64308_CR48","unstructured":"Arakawa M, Ishimura A, Arai Y, Kawabe K, Suzuki S, Ishige K, Ito Y. Characterization of 4-hydroxynonenal-induced neuronal death in cerebellar granule neurons. Neurosci Res. in press."},{"key":"64308_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/bdd.2510080407","volume":"8","author":"IA Cotgreave","year":"1987","unstructured":"Cotgreave IA, Mold\u00e9us P. Methodologies for the analysis of reduced and oxidized N-acetylcysteine in biological systems. Biopharm Drug Dispos. 1987;8:365\u201375.","journal-title":"Biopharm Drug Dispos."},{"key":"64308_CR50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","volume":"20","author":"MR Holdiness","year":"1991","unstructured":"Holdiness MR Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 1991;20:123\u201334.","journal-title":"Clin Pharmacokinet"},{"key":"64308_CR51","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1177\/106002809102501012","volume":"25","author":"WA Watson","year":"1991","unstructured":"Watson WA, McKinney PE. Activated charcoal and acetylcysteine absorption: Issues in interpreting pharmacokinetic data. DICP. 1991;25:1081\u20134.","journal-title":"DICP."},{"key":"64308_CR52","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0024-3205(98)00472-X","volume":"64","author":"M Martinez","year":"1999","unstructured":"Martinez M, Mart\u00ednez N, Hern\u00e1ndez AI, Ferr\u00e1ndiz ML. Hypothesis: Can N-acetylcysteine be beneficial in Parkinson\u2019s disease? Life Sci. 1999;64:1253\u20137.","journal-title":"Life Sci."},{"key":"64308_CR53","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1046\/j.1471-4159.2003.01580.x","volume":"84","author":"SA Farr","year":"2003","unstructured":"Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, Butterfield DA, Morley JE. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003;84:1173\u201383.","journal-title":"J Neurochem."},{"key":"64308_CR54","first-page":"7868","volume":"61","author":"EA Neuwelt","year":"2001","unstructured":"Neuwelt EA, Pagel MA, Hasler BP, Deloughery TG, Muldoon LL. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model. Cancer Res. 2001;61:7868\u201374.","journal-title":"Cancer Res."},{"key":"64308_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.heares.2004.02.007","volume":"193","author":"D Thomas Dickey","year":"2004","unstructured":"Thomas Dickey D, Muldoon LL, Kraemer DF, Neuwelt EA. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res. 2004;193:25\u201330.","journal-title":"Hear Res."},{"key":"64308_CR56","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1212\/WNL.59.9.1447","volume":"59","author":"MJ Edwards","year":"2002","unstructured":"Edwards MJ, Hargreaves IP, Heales SJ, Jones SJ, Ramachandran V, Bhatia KP, Sisodiya S. N-acetylcysteine and Unverricht-Lundborg disease: Variable response and possible side effects. Neurology. 2002;59:1447\u20139.","journal-title":"Neurology."},{"key":"64308_CR57","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1212\/WNL.47.5.1264","volume":"47","author":"RW Hurd","year":"1996","unstructured":"Hurd RW, Wilder BJ, Helveston WR, Uthman BM. Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine. Neurology. 1996;47:1264\u20138.","journal-title":"Neurology."},{"key":"64308_CR58","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1212\/WNL.52.2.426","volume":"52","author":"LM Selwa","year":"1999","unstructured":"Selwa LM. N-acetylcysteine therapy for Unverricht-Lundborg disease. Neurology. 1999;52:426\u20137.","journal-title":"Neurology."},{"key":"64308_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00207459109150342","volume":"57","author":"JA Jesberger","year":"1991","unstructured":"Jesberger JA, Richardson JS. Oxygen free radicals and brain dysfunction. Int J Neurosci. 1991;57:1\u201317.","journal-title":"Int J Neurosci."},{"key":"64308_CR60","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s007020070089","volume":"107","author":"R Galili","year":"2000","unstructured":"Galili R, Mosberg, Gil-Ad I, Weizman A, Melamed E, Offen D. Haloperidol-induced neurotoxicity-possible implications for tardive dyskinesia. J Neural Transm. 2000;107:479\u201390.","journal-title":"J Neural Transm."},{"key":"64308_CR61","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.wnf.0000191331.54649.e3","volume":"28","author":"O Sadan","year":"2005","unstructured":"Sadan O, Bahat-Stromza M, Gilgun-Sherki Y, Atlas D, Melamed E, Offen D. A novel brain-targeted antioxidant (AD4) attenuates haloperidol-induced abnormal movement in rats: Implications for tardive dyskinesia. Clin Neuropharmacol. 2005;28:285\u20138.","journal-title":"Clin Neuropharmacol."},{"key":"64308_CR62","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/378776a0","volume":"378","author":"J Busciglio","year":"1995","unstructured":"Busciglio J, Yankner BA. Apoptosis and increased generation of reactive oxygen species in Down\u2019s syndrome neurons in vitro. Nature. 1995;378:776\u20139.","journal-title":"Nature."},{"key":"64308_CR63","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3109\/07853899809002489","volume":"30","author":"AE Lehesjoki","year":"1998","unstructured":"Lehesjoki AE, Koskiniemi M. Clinical features and genetics of progressive myoclonus epilepsy of the Univerricht-Lundborg type. Ann Med. 1998;30:474\u201380.","journal-title":"Ann Med."},{"key":"64308_CR64","first-page":"159","volume":"31","author":"JB Lohr","year":"1995","unstructured":"Lohr JB, Browning JA. Free radical involvement in neuropsychiatric illnesses. Psychopharmacol Bull. 1995;31:159\u201365.","journal-title":"Psychopharmacol Bull."},{"key":"64308_CR65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF03159937","volume":"14","author":"JD Adams","year":"1991","unstructured":"Adams JD, Klaidman LK, Odunze IN, Shen HC, Miller CA. Alzheimer\u2019s and Parkinson\u2019s disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol Chem Neuropathol. 1991;14:213\u201326.","journal-title":"Mol Chem Neuropathol."},{"key":"64308_CR66","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S0140-6736(94)92347-7","volume":"344","author":"P Jenner","year":"1994","unstructured":"Jenner P. Oxidative damage in neurodegenerative disease. Lancet. 1994;344:796\u20138.","journal-title":"Lancet."},{"key":"64308_CR67","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3233\/JAD-2005-7206","volume":"7","author":"F Tchantchou","year":"2005","unstructured":"Tchantchou F, Graves M, Rogers E, Ortiz D, Shea TB N-acetyl cysteine alleviates oxidative damage to central nervous system of ApoE-deficient mice following folate and vitamin E-deficiency. J Alzheimers Dis. 2005;7:135\u20138 discussion 173.","journal-title":"J Alzheimers Dis."},{"key":"64308_CR68","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1567205053585855","volume":"2","author":"S Tucker","year":"2005","unstructured":"Tucker S, Ahl M, Bush A Westaway D, Huang X, Rogers JT. Pilot study of the reducing effect on amyloidosis in vivo by three FDA pre-approved drugs via the Alzheimer\u2019s APP 5\u2032 untranslated region. Curr Alzheimer Res. 2005;2:249\u201354.","journal-title":"Curr Alzheimer Res."},{"key":"64308_CR69","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1212\/WNL.47.4.1037","volume":"47","author":"EJ Pappert","year":"1996","unstructured":"Pappert EJ, Tangney CC, Goetz CG, Ling ZD, Lipton JW, Stebbins GT, Carvey PM. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson\u2019s disease patients: Dose-response study and correlations with plasma levels. Neurology. 1996;47:1037\u201342.","journal-title":"Neurology."},{"key":"64308_CR70","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1056\/NEJM199301213280305","volume":"328","author":"The Parkinson Study Group","year":"1993","unstructured":"The Parkinson Study Group Effects of tocopherol and deprenyl on the progression of disability in early Parkinson\u2019s disease. N Engl J Med. 1993;328:176\u201383.","journal-title":"N Engl J Med."},{"key":"64308_CR71","first-page":"51","volume":"37","author":"DK Reilly","year":"1983","unstructured":"Reilly DK, Hershey L, Rivera-Calimlim L, Shoulson I. On-off effects in Parkinson\u2019s disease: A controlled investigation of ascorbic acid therapy. Adv Neurol. 1983;37:51\u201360.","journal-title":"Adv Neurol."},{"key":"64308_CR72","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neulet.2004.03.072","volume":"363","author":"SW Park","year":"2004","unstructured":"Park SW, Kim SH, Park KH, Kim SD, Kim JY, Baek SY, Chung BS, Kang CD. Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson\u2019s disease. Neurosci Lett. 2004;363:243\u20136.","journal-title":"Neurosci Lett."},{"key":"64308_CR73","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0891-5849(03)00329-0","volume":"35","author":"TN Behar","year":"2003","unstructured":"Behar TN, Colton CA. Redox regulation of neuronal migration in a Down Syndrome model. Free Radic Biol Med. 2003;35:566\u201375.","journal-title":"Free Radic Biol Med."}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1080\/14734220601142878.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1080\/14734220601142878\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1080\/14734220601142878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1080\/14734220601142878.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:29:42Z","timestamp":1744147782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1080\/14734220601142878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["64308"],"URL":"https:\/\/doi.org\/10.1080\/14734220601142878","relation":{},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"1 December 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}